Pharmaceutical & Medical Devices Promotion and Development Scheme
Pharmaceutical & Medical Devices Promotion and Development Scheme
Pharmaceutical and Medical Devices Promotion and Development Scheme (PMPDS) aims to facilitate growth and development of pharmaceutical sector through study/survey reports, awareness programs, creation of databases and promotion of industry.
Since FY2021-22, Department has conducted 25 studies and evaluations on topics of importance to the Department and has organized/supported 65 events/workshops/seminars/webinars across the country to sensitize the pharmaceutical and medical devices industry on various topics through academic institutions, government autonomous bodies, firms empanelled with Government of India, National/State level industry associations, non-profit companies/organization in pharmaceutical & medical devices sector, private companies of good repute and Government agencies.
Seminars/workshops conducted under the scheme are organised at various locations across the country including Andhra Pradesh and are open to participants from the pharmaceutical and medical sectors nationwide.
The total amount sanctioned and disbursed under PMPDS year-wise is given at Annexure-I. The number of seminars, conferences, workshops, conventions and exhibitions supported with financial assistance under PMPDS during the last three years is given at Annexure-II.
The details of mega events organised under PMPDS including India Pharma and India Medical Device meets, locations, participation from different states, total expenditure incurred including Grant-in-Aid under the PMPDS and outcomes achieved are at Annexure-III.
Department of Pharmaceuticals has supported 20 events with non-financial logo support under PMPDS since 2021-22. The non-financial logo support is provided to various organizations for Pharma and Medical Device events in compliance with the scheme guidelines.
Annexure I
Details of amount sanctioned and disbursed for preparing various study reports and organizing various seminars, conferences, conventions, workshop and exhibitions under PMPDS during last five years.
S. No.
Item
2021-22
2022-23
2023-24
2024-25
2025-26
(as on 12.3.2026)
1.
Amount sanctioned (₹ in lakh) for studies and events
2.00
3.00
7.00
4.00
4.83
2.
Amount Disbursed (₹ in lakh) for studies and events
1.20
0.81
2.77
2.02
1.80
Annexure II
Details of number of seminars, conferences, workshops, conventions and exhibitions supported with financial assistance under PMPDS during the last three years
S. No.
Item
2022-23
2023-24
2024-25
1.
No. of seminars, conferences, workshops, conventions and exhibitions supported with financial assistance
3
11
14
Annexure III
Details of mega events organised under PMPDS including India Pharma and India Medical Device meets, their locations, participating states, total expenditure incurred including Grant-in-Aid under the PMPDS and outcomes achieved.
S. No
Name of Mega Event
Date of event
Location(s)
Participating States
Total Expenditure incurred
(₹ in lakh)
Key Outcomes Achieved
1.
India Pharma and India Medical Device 2021 (Hybrid Mode)
25.2.2021 to 26.2.2021
and
1.3.2021 to 2.3.2021
FICCI, Federation House, New Delhi
Maharashtra, Karnataka, Gujarat, Rajasthan, Delhi, Haryana, Madhya Pradesh, Orissa, Goa, Uttar Pradesh, Telangana, Chhattisgarh, Kerala, Himachal Pradesh, Uttarakhand, Punjab and Andhra Pradesh through Andhra Pradesh MedTech Zone (AMTZ)
Maharashtra, Karnataka, Gujarat, Rajasthan, Delhi, Haryana, Madhya Pradesh, Orissa, Goa, Uttar Pradesh, Telangana, Chhattisgarh, Kerala, Himachal Pradesh, Uttarakhand, Punjab and Andhra Pradesh through Andhra Pradesh MedTech Zone (AMTZ)
18.52
The India Pharma & India Medical Devices 2021 Conference advanced dialogue between government and industry on policy priorities and sectoral reforms. Key outcomes included emphasis on strengthening domestic manufacturing, enhancing resilient supply chains, promoting innovation and R&D, improving healthcare access, and supporting digital health and advanced medical technologies to position India as a global hub for affordable medicines and medical device manufacturing.
2.
India Pharma and India Medical Device 2022
25.4.2022 to 27.4.2022
Dr. Ambedkar International Centre, New Delhi
85.80
The India Pharma 2022 and India Medical Device 2022 Conferences led to key outcomes including strengthened dialogue between government and industry on policy support and ease of doing business, promotion of domestic manufacturing and resilient supply chains, and greater focus on innovation, digital health, and advanced medical technologies. The deliberations also emphasized regulatory collaboration, value-based healthcare, and enhanced investments through industrial clusters and medical device parks to position India as a global hub for pharmaceuticals and medical devices.
3.
India Pharma and India Medical Device 2023
26.5.2023 to 27.5.2023
Hotel Ashok, New Delhi
113.73
The 8th Edition of India Pharma & India Medical Devices 2023 strengthened collaboration among government, regulators, industry, and academia to advance domestic manufacturing, innovation, and global competitiveness. Key outcomes included emphasis on scaling MedTech innovations to large-scale manufacturing, strengthening quality and R&D capabilities, promoting digital transformation and biosimilars in pharmaceuticals, and fostering industry–academia partnerships to support sustainable growth of India’s healthcare ecosystem.
4.
India Medtech Expo 2023
17.8.2023 to 19.8.2023
Gandhinagar, Gujarat
815.10
The India MedTech Expo 2023 showcased India’s growing capabilities in the medical devices sector and strengthened engagement among policymakers, industry, start-ups, academia, and international stakeholders. Key outcomes included promotion of indigenous innovations and start-ups, facilitation of global business partnerships through buyer–seller meetings, identification of investment opportunities, and enhanced collaboration in R&D, skill development, and advanced healthcare technologies, reinforcing India’s position as an emerging hub for medical device manufacturing and innovation.
This information was given by Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, in a written reply in the Lok Sabha today.